What is Magline?
Founded in 2000, Magline, Inc. operates at the intersection of agricultural science and chemical engineering. The company specializes in the manufacturing and distribution of foliar plant micronutrients, utilizing a proprietary carrier molecule that distinguishes its offerings from traditional chelate-based products. By facilitating the direct delivery of essential nutrients—including iron, zinc, manganese, boron, and molybdenum—Magline enables crops to optimize enzymatic reactions such as photosynthesis. This technological edge, validated by industry tests demonstrating superior plant dry mass weight, positions Magline as a critical partner for large-scale agricultural operations and home gardening enthusiasts alike. Their flagship product line, Ultra Trace, represents a shift toward more efficient, economical, and high-performance nutrient management systems.
How much funding has Magline raised?
Magline has raised a total of $2.3M across 2 funding rounds:
Debt
$1M
Debt
$1.3M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.3M led by PPP
Key Investors in Magline
PPP
Public-Private Partnership
What's next for Magline?
With the recent capital deployment, Magline is well-positioned to accelerate its market penetration and refine its production capabilities at its Plainview, Texas facility. The strategic focus will likely center on expanding the reach of its N-P-K and calcium-magnesium integrated solutions, which provide a comprehensive nutritional program for diverse crop types. As the global agricultural community faces increasing pressure to maximize yields under varying environmental conditions, Magline's commitment to research-driven, cost-effective solutions provides a robust foundation for long-term growth. Future initiatives will likely involve scaling distribution networks and continuing the iterative development of its proprietary carrier technology to maintain its competitive advantage in the global micronutrient market.
See full Magline company page
